Literature DB >> 3090346

[Diphosphonate for the prevention of an increased ossification process].

W Forth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090346     DOI: 10.1007/bf01735322

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  14 in total

1.  The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo.

Authors:  H A Fleisch; R G Russell; S Bisaz; R C Mühlbauer; D A Williams
Journal:  Eur J Clin Invest       Date:  1970-03       Impact factor: 4.686

2.  Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study.

Authors:  J Guncaga; T Lauffenburger; C Lentner; M A Dambacher; H G Haas; H Fleisch; A J Olah
Journal:  Horm Metab Res       Date:  1974-01       Impact factor: 2.936

3.  In vivo distribution of 14C-labeled ethylene-1-hydroxy-1,1-diphosphonate in normal and treated young rats. An autoradiographic and ultrastructural study.

Authors:  A Larsson; M Rohlin
Journal:  Toxicol Appl Pharmacol       Date:  1980-03-15       Impact factor: 4.219

Review 4.  Experimental basis for the clinical use of diphosphonates in Paget's disease of bone.

Authors:  H Fleisch
Journal:  Arthritis Rheum       Date:  1980-10

5.  Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

Authors:  R R Recker; P D Saville
Journal:  Toxicol Appl Pharmacol       Date:  1973-04       Impact factor: 4.219

6.  Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.

Authors:  C Alexandre; P J Meunier; C Edouard; R A Khairi; C C Johnston
Journal:  Metab Bone Dis Relat Res       Date:  1981

7.  Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.

Authors:  M R Khairi; P Meunier; C Edouard; P Courpron; J Bernard; G P DeRosa; C C Johnston
Journal:  Calcif Tissue Res       Date:  1977-05

8.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

9.  Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).

Authors:  C M Alexandre; M C Chapuy; E Vignon; C Edouard; C C Johnston; P J Meunier
Journal:  Clin Orthop Relat Res       Date:  1983-04       Impact factor: 4.176

10.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.